SCHEMBL4910296

SCHEMBL4910296

CN(C)CCNc1ccnc2ccc([N+](=O)[O-])cc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 1/20 0.66
CDK8 P49336 1/20 0.66
HTR1A P08908 3/20 0.49
ADRA1D P25100 3/20 0.49
ADRA1A P35348 3/20 0.49
ADRA1B P35368 3/20 0.49
FERMT2 Q96AC1 1/20 0.46
ALDH1A1 P00352 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KMT2A Q03164 3/20 0.45
USP2 O75604 2/20 0.45
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 2/20 0.42
POLB P06746 2/20 0.42
THRB P10828 1/20 0.42
MAPK1 P28482 1/20 0.42
MCL1 Q07820 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SLC40A1 Q9NP59 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903360 0.90 FERMT2 (0.55) CCNCCDK8HTR1AADRA1DADRA1A
SCHEMBL2990471 0.83 FERMT2 (0.65) CCNCCDK8HTR1AADRA1DADRA1A
SCHEMBL15483266 0.83 CCNC (0.54) CCNCCDK8HTR1AADRA1DADRA1A
SCHEMBL4912004 0.82 ALDH1A1 (0.45) CCNCCDK8ALDH1A1NPSR1KMT2A
SCHEMBL21750432 0.80 CCNC (1.00) CCNCCDK8HTR1AADRA1DADRA1A
SCHEMBL2621805 0.78 CCNC (0.62) CCNCCDK8HTR1AADRA1DADRA1A
SCHEMBL1219722 0.77 CYP2C19 (0.51) ALDH1A1NPSR1MAPTPOLBHTT
SCHEMBL26640796 0.75 MAPT (0.58) ALDH1A1NPSR1KMT2AMAPTL3MBTL1
SCHEMBL1594797 0.75 ALDH1A1 (0.72) ALDH1A1NPSR1KMT2AMAPTKDM4E
SCHEMBL4913166 0.74 HTR1A (0.73) HTR1AADRA1DADRA1AADRA1BFERMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045538-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2008-02-21 US disclosed
US-6992089-B2 Nitro and amino substituted topoisomerase agents RUTGERS, THE UNIVERSITY OF NEW JERSEY (US) 2006-01-31 US disclosed
US-20040102443-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045538-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B CCNC 247/4885CDK8 439/4885HTR1A 2567/4885
US-20040102443-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B CCNC 532/4885CDK8 671/4885HTR1A 1558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.